Product Information
ASMANEX TWISTHALER 220 MCG #14 is a brand product labeled by Organon LLC, priced at $36.9800 per EA under NDC 78206011403. Its NADAC has been published 111 times since Aug 21, 2024.
FDA first approved this application on Mar 30, 2005.
The High Outlier badge above means this manufacturer's average price in the Mometasone Furoate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
220 ug/1
Manufacturer
Organon LLCNDC
78206011403
Classification
Brand
Dosage Form
INHALANT
Route
RESPIRATORY (INHALATION)
Effective Date
4/22/2026
Active Ingredients
MOMETASONE FUROATEApproval Type
New Drug (NDA)
FDA Application
NDA021067FDA Approved
3/30/2005
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for ASMANEX TWISTHALER 220 MCG #14 has been published 111 times since Aug 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $36.9800 per EA |
|---|---|
| All-time high | $37.1460 (Jul 16, 2025) |
| All-time low | $36.9157 (Jan 22, 2025) |
| 52-week high | $36.9800 |
| 52-week low | $36.9480 |
| Median price | $36.9480 |
| Average price | $36.9619 |
| Largest weekly change | -0.4% (Jul 23, 2025) |
| Weeks tracked | 111 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mometasone Furoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ASMANEX TWISTHALER 220 MCG #14?
The current National Average Drug Acquisition Cost (NADAC) for ASMANEX TWISTHALER 220 MCG #14, manufactured by Organon LLC, is $36.9800 per EA (NDC 78206011403), effective Sep 30, 2026.
How has the price of ASMANEX TWISTHALER 220 MCG #14 changed over time?
Over the history we have for it, the NADAC for ASMANEX TWISTHALER 220 MCG #14 has held within roughly two percent of its current level. It has been tracked across 111 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for ASMANEX TWISTHALER 220 MCG #14?
Since Aug 21, 2024, the NADAC for ASMANEX TWISTHALER 220 MCG #14 has ranged from a low of $36.9157 (Jan 22, 2025) to a high of $37.1460 (Jul 16, 2025), with a median of $36.9480 per EA.
Are there cheaper alternatives to ASMANEX TWISTHALER 220 MCG #14?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ASMANEX TWISTHALER 220 MCG #14 in a comparable dosage form, but none are currently priced below it.
Who manufactures ASMANEX TWISTHALER 220 MCG #14?
ASMANEX TWISTHALER 220 MCG #14 (NDC 78206011403) is labeled by Organon LLC, and CMS classifies it as a brand product.